2024-12-31-accounts - Sono Vivo

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

Trustees' Annual Report for the period

Period start date Period end date 1[st] January 2024 31[st] December 2024

From To Section A Reference and administration details Charity name Sono Vivo Other names charity is known by N/A Registered charity number (if any) 1170054 Charity's principal address 35 St James’s Road Gravesend Kent Postcode DA11 0HF ~~ee~~ Names of the charity trustees who manage the charity Dates acted if not for whole Name of person (or body) entitled Trustee name Office (if any) year to appoint trustee (if any) 1 Richard Meyrick Chairman 2 Tom Mann Treasurer 3 Felicity Meyrick - 4 Susan Harrison - 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ~~ae~~ Names of the trustees for the charity, if any, (for example, any custodian trustees) Name Dates acted if not for whole year

Section A Reference and administration details

Names of the charity trustees who manage the charity

TAR

Names and addresses of advisers (Optional information)

Type of adviser Name Address

Name of chief executive or names of senior staff members (Optional information)

Section B Structure, governance and management

Description of the charity’s trusts

Type of governing document

CIO Foundation Constitution

(eg. trust deed, constitution)

Charitable Incorporated Organisation How the charity is constituted

(eg. trust, association, company)

Appointed by the Board of Trustees of Sono Vivo Trustee selection methods

(eg. appointed by, elected by)

Additional governance issues (Optional information)

You may choose to include additional information, where relevant, about:

policies and procedures adopted for the induction and training of trustees;
the charity’s organisational structure and any wider network with which the charity works;
relationship with any related parties;
trustees’ consideration of major risks and the system and procedures to manage them.

Section C Objectives and activities

Summary of the objects of the charity set out in its governing document

For the public benefit the prevention of sickness and the preservation of health by financially supporting various selected charities that are focused on both the treatment and support of people suffering from cancer, and cancer research

TAR

Sono Vivo benefits the public through the prevention of sickness and the preservation of health by financially supporting various selected charities that are focused on both the treatment and support of people suffering from cancer, and cancer research. The organisation is grant-making and it supports the organisations listed below. The trustees have a formal grant-making policy which lays down the relevant criteria for making a grant to another organisation. • The Royal Marsden Charity • Oracle Cancer Trust • Summary of the main Macmillan Cancer Support activities undertaken for the • Institute of Cancer Research public benefit in relation to • Cancer Research UK these objects (include within Other cancer charities will be considered for financial support over time this section the statutory but currently these are the ones the trustees have identified as ones they declaration that trustees have wish to support. had regard to the guidance issued by the Charity In its decision making, the trustees of Sono Vivo specifically take into Commission on public consideration their duty to give due regard to the Charity Commission’s benefit) public benefit guidance when exercising any powers or duties to which the guidance is relevant.

Additional details of objectives and activities (Optional information)

The founders of Sono Vivo are cancer survivors and professional musicians. Part of Sono Vivo’s activities are to stage music concerts, the proceeds of which are used to provide grants for other cancer charities.

You may choose to include further statements, where relevant, about:

policy on grantmaking;
policy programme related investment;
contribution made by volunteers.

TAR

Section D Achievements and performance

Summary of the main achievements of the charity during the year

Sono Vivo did not stage music concerts during the year. The founders of Sono Vivo are professional musicians who are also cancer survivors. We support our charitable aim by staging music concerts, the proceeds of which are used to provide grants for other cancer charities.

TAR

Section E Financial review

The trustees of Sono Vivo have determined that the minimum level of Brief statement of the reserves of Sono Vivo are £500. This amount represents the maximum charity’s policy on reserves level of expenses the organisation would reasonably expect to incur in the period of one year. Our closing bank balance is £1,506.02, leaving reserves well in excess of this minimum. Details of any funds materially Not applicable in deficit ~~ee~~

Further financial review details (Optional information)

You may choose to include additional information, where relevant about:

the charity’s principal sources of funds (including any fundraising);
how expenditure has supported the key objectives of the charity;
investment policy and objectives including any ethical investment policy adopted.
Section F Other optional information
~~_~~ Section G Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Tom Brodie Mann, CFA

Treasurer

27[th] October 2025

TAR

Charity Name No (if any) Sono Vivo 1170054 Receipts and payments accounts CC16a For the period Period start date Period end date To from 1st Jan 2024 31st Dec 2024 ~~ee~~

Section A Receipts and payments

		Unrestricted funds		Restricted funds	Restricted	Endowment funds	Endowment funds	Total funds	Last year
		to the nearest £	to the nearest	to the nearest £	to the nearest £	to the nearest £	to the nearest £	to the nearest £	to the nearest £	to the nearest £
A1 Receipts
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
*Sub total*(Gross income for
AR)	AR)	-		-	-	-	-	-	-	-
A2 Asset and investment sales, (see table). - - - - - - - - - Sub total - - - - - *Total receipts* - - - - - ~~——————~~
A3 Payments
				-	-	-	-	-	-	-
				-	-	-	-	-	-	-
				-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
		-		-	-	-	-	-	-	-
**Sub total **		-		-	-	-	-	-	-	-
A4 Asset and investment purchases, (see table) - - - - - - - - Sub total - - - - - *Total payments* - - - - - ~~——————~~
*Net of receipts/(payments)* A5 Transfers between funds A6 Cash funds last year end *Cash funds this year end*	- - - - - - - - - - 1,506 - - 1,506 - 1,506 - - 1,506 - ~~===>>~~

CCXX R1 accounts (SS)

27/10/2025

Section B Statement of assets and liabilities at the end of the period	Section B Statement of assets and liabilities at the end of the period	Section B Statement of assets and liabilities at the end of the period
		Unrestricted Restricted	Endowment
Categories	Details	funds funds	funds
B1 Cash funds	to nearest £ to nearest £ to nearest £ 1,506 - - - - - - - - 1,506 - - OK OK OK *Total cash funds* (agree balances with receipts and payments account(s)) Barclays Bank Account ~~—S=~~
		Unrestricted Restricted	Endowment
		funds funds	funds
	Details	to nearest £ to nearest £	to nearest £
B2 Other monetary assets	- - - - - - - - - - - - - - - - - - ~~===>~~
	Details	Fund to which asset belongs Cost (optional)	Current value (optional)
B3 Investment assets	- - - - - - - - - - ~~—===—=~~
	Details	Fund to which asset belongs Cost (optional)	Current value (optional)
B4 Assets retained for the charity’s own use	- - - - - - - - - - - - - - - - - - ~~===>~~
		Fund to which Amount due	When due
	Details	liability relates (optional)	(optional)
B5 Liabilities	- - - - - ~~===~~
Signed by one or two trustees on behalf of all the trustees	Date of approval 27/10/2025 Print Name Tom Brodie Mann,CFA Signature ~~eT~~
CCXX R2 accounts (SS)	2		27/10/2025

CCXX R2 accounts (SS)

27/10/2025